Literature DB >> 2841310

Transformation with SV40 virus prevents retinoic acid inhibition of plasma membrane NADH diferric transferrin reductase in rat liver cells.

I L Sun1, W Toole-Simms, F L Crane, D J Morré, H Löw, J Y Chou.   

Abstract

Retinoic acid inhibits the reduction of diferric transferrin through the transplasma membrane electron transport system on fetal rat liver cells infected with a temperature-sensitive SV40 virus when the cells are in the nontransformed state cultured at 40 degrees C. When the cells are in the transformed state (grown at the permissive 33 degrees C temperature), retinoic acid does not inhibit the diferric transferrin reduction. Inhibition of activity of nontransformed cells is specific for retinoic acid with only slight inhibition by retinol and retinyl acetate at higher concentrations. Isolated rat liver plasma membrane NADH diferric transferrin reductase is also inhibited by retinoic acid. The effect of transformation with SV40 virus to decrease susceptibility to retinoic acid inhibition stands in contrast to much greater adriamycin inhibition of diferric transferrin reduction in the transformed cells than in nontransformed cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841310     DOI: 10.1007/BF00769639

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  36 in total

1.  Diferric transferrin reduction stimulates the Na+/H+ antiport of HeLa cells.

Authors:  I L Sun; R Garcia-Cañero; W Liu; W Toole-Simms; F L Crane; D J Morré; H Löw
Journal:  Biochem Biophys Res Commun       Date:  1987-05-29       Impact factor: 3.575

2.  Transplasmalemma electron transport is changed in simian virus 40 transformed liver cells.

Authors:  I L Sun; P Navas; F L Crane; J Y Chou; H Löw
Journal:  J Bioenerg Biomembr       Date:  1986-12       Impact factor: 2.945

3.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

4.  Bleomycin control of transplasma membrane redox activity and proton movement in HeLa cells.

Authors:  I L Sun; F L Crane
Journal:  Biochem Pharmacol       Date:  1985-03-01       Impact factor: 5.858

5.  Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed, and tumor cells in vitro.

Authors:  R Lotan; G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1977-12       Impact factor: 13.506

6.  Modification of transmembrane electron transport activity in plasma membranes of simian virus 40 transformed pineal cells.

Authors:  I L Sun; F L Crane; J Y Chou
Journal:  Biochim Biophys Acta       Date:  1986-05-29

7.  The antitumor drug, cis diamminedichloro-platinum, inhibits trans plasmalemma electron transport in HeLa cells.

Authors:  I L Sun; F L Crane
Journal:  Biochem Int       Date:  1984-09

8.  Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment.

Authors:  A Yen; M Forbes; G DeGala; J Fishbaugh
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

9.  Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system.

Authors:  H Löw; C Grebing; A Lindgren; M Tally; I L Sun; F L Crane
Journal:  J Bioenerg Biomembr       Date:  1987-10       Impact factor: 2.945

10.  Ruthenium ammine complexes as electron acceptors for growth stimulation by plasma membrane electron transport.

Authors:  J F Laliberté; I L Sun; F L Crane; M J Clarke
Journal:  J Bioenerg Biomembr       Date:  1987-02       Impact factor: 2.945

View more
  2 in total

Review 1.  Electron and proton transport across the plasma membrane.

Authors:  F L Crane; I L Sun; R Barr; H Löw
Journal:  J Bioenerg Biomembr       Date:  1991-10       Impact factor: 2.945

2.  Modification of transplasma membrane oxidoreduction by SV40 transformation of 3T3 cells.

Authors:  H Löw; F L Crane; C Grebing; M Isaksson; A Lindgren; I L Sun
Journal:  J Bioenerg Biomembr       Date:  1991-12       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.